Wird geladen...
Improving quality, affordability, and equity of multiple sclerosis care
OBJECTIVE: The prevailing approaches to selecting multiple sclerosis (MS) disease modifying therapies (DMTs) have contributed to exponential increases in societal expenditures and out‐of‐pocket expenses, without compelling evidence of improved outcomes. Guidance is lacking regarding when and in whom...
Gespeichert in:
| Veröffentlicht in: | Ann Clin Transl Neurol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045931/ https://ncbi.nlm.nih.gov/pubmed/33751857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51326 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|